NCT06096077View on ClinicalTrials.gov

Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions

Angioedema

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors

lead

Methodist Health System

OTHER